Glutathione S-transferases and hepatocarcinogenesis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

30 citing papers in PubMed.

1. Ameliorative Effects ofAntioxidants (Basel, Switzerland) · 2021
   Article
2. PlasmaCanadian journal of gastroenterology & hepatology · 2019
   Article
3. Chemopreventive effects of korean red ginseng extract on rat hepatocarcinogenesis.Journal of Cancer · 2015
   Article
4. Long-term Branched Chain Amino Acid Supplementation Ameliorates Diethylnitrosamine-induced Liver Glutathione S-transferase-p Positivity in Zucker Fatty Rats.Journal of clinical and experimental hepatology · 2013
   Article
5. Decreased Diethylnitrosamine-induced Liver Preneoplastic Lesions by Estradiol-3-benzoate Treatment.Toxicological research · 2011
   Article
6. Structure-Based Design of Anticancer Prodrug PABA/NO.Drug design, development and therapy · 2008
   Article
7. Existence of a no effect level for MeIQx hepatocarcinogenicity on a background of thioacetamide-induced liver damage in rats.Cancer science · 2006
   Article
8. Does glutathione S-transferase Pi (GST-Pi) a marker protein for cancer?Molecular and cellular biochemistry · 2003
   Review
9. Effect of Boschniakia rossica on expression of GST-P, p53 and p21(ras)proteins in early stage of chemical hepatocarcinogenesis and its anti-inflammatory activities in rats.World journal of gastroenterology · 2000
   Article
10. Inhibition of early-phase exogenous and endogenous liver carcinogenesis in transgenic rats harboring a rat glutathione S-transferase placental form gene.Japanese journal of cancer research : Gann · 1998
    Article
11. Expression of glutathione S-transferase placental mRNA in hepatic preneoplastic lesions in rats.World journal of gastroenterology · 1998
    Article
12. Tissue-specific activation of tumor marker glutathione transferase P transgenes in transgenic rats.Journal of cancer research and clinical oncology · 1995
    Article
13. The expression of placental-type glutathione S-transferase (GST-pi) in human cutaneous squamous cell carcinoma and normal human skin.Virchows Archiv : an international journal of pathology · 1995
    Article
14. Constitutive over-expression of transforming growth factor-alpha in rat liver epithelial cells leads to increased cell cycling without transformation.In vitro cellular & developmental biology. Animal · 1994
    Article
15. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints.Environmental health perspectives · 1993
    Article
16. Glutathione S-transferase expression in benign and malignant ovarian tumours.British journal of cancer · 1993
    Article
17. Trans-activation of glutathione transferase P gene during chemical hepatocarcinogenesis of the rat.Proceedings of the National Academy of Sciences of the United States of America · 1993
    Article
18. Thein utero initiation with DMN alters the complement of cytosolic glutathione S-transferases and the phenobarbital-induced expression ofc-jun andc-myc oncogenes in primary neonatal rat hepatocytes.Cytotechnology · 1993
    Article
19. Phenotypic properties of liver tumors induced by dehydroepiandrosterone in F-344 rats.Japanese journal of cancer research : Gann · 1992
    Article
20. mRNA levels of catalytic subunits of protein phosphatases 1, 2A, and 2C in hepatocarcinogenesis.Japanese journal of cancer research : Gann · 1992
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as